|
Market Closed -
Nasdaq
21:00:00 09/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 510.08 USD | +1.36% |
|
+1.06% | +12.51% |
| Market Cap | 129B 115B 107B 97.7B 184B 12,512B 185B 1,292B 506B 6,378B 485B 475B 20,464B | P/E 2026 * |
52.4x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 124B 110B 103B 93.51B 176B 11,976B 177B 1,237B 484B 6,104B 465B 454B 19,587B | EV / Sales 2026 * |
9.33x | EV / Sales 2027 * | 8.22x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
CBOE
| VRTX | Real-time | |
|
London S.E.
| 0QZU | Delayed | |
|
Tradegate
| VX1 | Real-time | |
|
Borsa Italiana
| 1VRTX | End-of-day quote | |
|
Xetra
| VX1 | Delayed | |
|
Boerse Muenchen
| VX1 | Real-time | |
|
Mexican S.E.
| VRTX * | End-of-day quote | |
|
Börse Stuttgart
| VX1 | Delayed | |
|
Deutsche Boerse AG
| VX1 | Delayed | |
|
Wiener Boerse
| VRTX | End-of-day quote | |
|
CBOE
| 0QZU | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | +1.36% | ||
| 1 week | +1.06% | ||
| Current month | -2.43% | ||
| 1 month | -0.87% | ||
| 3 months | +5.09% | ||
| 6 months | +16.92% | ||
| Current year | +12.51% |
| 1 week | 496.15 |  | 514.9 |
| 1 month | 496.15 | | 529.89 |
| Current year | 412.27 | | 560.25 |
| 1 year | 402.58 | | 560.25 |
| 3 years | 341.9 | | 560.25 |
| 5 years | 177.71 | | 560.25 |
| 10 years | 71.46 | | 560.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 31/03/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 09/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 31/12/1997 |
Jeffrey Leiden
CHM | Chairman | 70 | 30/04/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 17/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/08/26 | Free | Controller/Auditor | 5,000 | 0.0020% | ||
| 27/08/26 | Don | Director | -6,000 | 0.0024% | ||
| 21/07/26 | Free | General Counsel | 8,251 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.36% | +1.06% | +25.08% | +41.46% | 129B | |
| +0.83% | +3.19% | +41.49% | +103.56% | 1,051B | |
| +1.93% | +2.11% | +37.08% | +65.09% | 630B | |
| +1.49% | +5.19% | +19.94% | +85.69% | 489B | |
| +2.26% | +0.90% | +69.32% | +40.53% | 359B | |
| +1.45% | +3.50% | +23.29% | +41.62% | 344B | |
| +1.17% | +2.37% | +13.47% | +33.64% | 272B | |
| +0.89% | +1.08% | -6.13% | +9.29% | 246B | |
| +1.82% | +2.94% | +42.99% | +52.95% | 224B | |
| +2.77% | +4.44% | +29.01% | +98.99% | 187B | |
| Average | +1.60% | +2.38% | +29.55% | +57.28% | 393.3B | |
| Weighted average by Cap. | +1.47% | +2.40% | +33.08% | +68.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.26B 11.84B 11.01B 10.02B 18.9B 1,283B 18.99B 132B 51.9B 654B 49.77B 48.69B 2,098B | 14.56B 13B 12.09B 11B 20.76B 1,409B 20.85B 146B 57.01B 718B 54.67B 53.47B 2,305B |
| Net income | 2.54B 2.26B 2.11B 1.92B 3.62B 245B 3.63B 25.34B 9.93B 125B 9.52B 9.31B 401B | 4.84B 4.32B 4.02B 3.65B 6.9B 468B 6.93B 48.34B 18.94B 239B 18.16B 17.76B 766B |
| Net Debt | -5.54B -4.95B -4.6B -4.19B -7.91B -537B -7.94B -55.42B -21.71B -274B -20.82B -20.36B -878B | -9.58B -8.56B -7.96B -7.24B -13.66B -927B -13.72B -95.77B -37.52B -473B -35.98B -35.19B -1,517B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/10/26 | US$510.08 | +1.36% | 1,480,861 |
| 08/10/26 | US$503.25 | -0.47% | 1,487,972 |
| 07/10/26 | US$505.64 | +0.66% | 806,840 |
| 06/10/26 | US$502.31 | -0.24% | 775,071 |
| 05/10/26 | US$503.50 | -0.24% | 915,135 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
